Novartis Investigative Site

Constanța 900591

0 studies enrolling now · 2 studies all time

What they study most

Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis

Studies at this site

• Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
• Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND) — Completed